Wells Messersmith
Division Head
Credentials: · · ·
History
Present
- Until 2004
Johns Hopkins University School of Medicine Program
- Until 2001
- Until 1999
Research
Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2021 · 1,286 citations
Patient-derived tumour xenografts as models for oncology drug development
Review · Nature Reviews Clinical Oncology · 2012 · 1,030 citations
NCCN Guidelines Insights: Colon Cancer, Version 2.2018
Journal of the National Comprehensive Cancer Network · 2018 · 777 citations
46 papers
41 papers
35 papers
29 papers · 21 as a fellow
19 papers · 1 as a fellow
- SL
18 papers
16 papers
16 papers
Grants
- 2014–2027
The Johns Hopkins Translational Science Team and Consortium for ETCTN Studies
National Cancer Institute · UM1
PI · $13M · Johns Hopkins University
- 2010–2016
Biomarker-Driven Src Inhibitor Studies in Colorectal Cancer Patients
National Cancer Institute · R01
Contact PI · $1.5M · University of Colorado Denver
- 2008–2011
Evaluation of Src Inhibition in Pancreas Cancer
National Cancer Institute · R21
Contact PI · $610.3K · University of Colorado Denver
- 2006–2011
Evaluation of BAY43-9006/Cetuximab in Colorectal Cancer
National Cancer Institute · R21
Contact PI · $572.7K · University of Colorado Denver
Clinical trials
- 2026–2027
Principal investigator · Recruiting · Phase 1, Phase 2
National Cancer Institute (NCI)
- 2022–2024
Principal investigator · Terminated · Phase 2
University of Colorado, Denver
- 2019–2023
Predictors of Physical Activity Maintenance in Colorectal Cancer Survivors
Principal investigator · Completed · Phase 3
University of Colorado, Denver
- 2018–2022
Investigating Cabozantinib in Patients With Refractory Metastatic Colorectal Cancer
Principal investigator · Completed · Phase 2
Academic Thoracic Oncology Medical Investigators Consortium